Antitumoral activity of quinoxaline derivatives: A systematic review

Area of Science:

• Medicinal Chemistry
• Oncology
• Pharmacology

Background:

• Cancer remains a significant global health burden and leading cause of mortality.
• Current chemotherapy drugs often lack specificity, leading to severe side effects.
• There is a critical need for novel, safer, and more effective anticancer agents.

Purpose of the Study:

• To review and synthesize research on the anticancer potential of quinoxaline derivatives.
• To discuss the therapeutic efficacy of these compounds against diverse tumor types.
• To highlight recent advancements in quinoxaline-based cancer therapeutics.

Main Methods:

• Systematic literature review of scientific articles.
• Focus on studies published between July 2013 and July 2018.
• Analysis of research detailing the synthesis and biological evaluation of quinoxaline derivatives.

Main Results:

• Quinoxaline derivatives demonstrate significant cytotoxic activity against various cancer cell lines.
• Several derivatives exhibit promising anticancer effects in preclinical studies.
• The structural diversity of quinoxalines allows for targeted drug design.

Conclusions:

• Quinoxaline derivatives represent a promising class of novel chemotherapeutic agents.
• These compounds offer potential for developing more targeted and less toxic cancer therapies.
• Further research is warranted to advance quinoxaline derivatives into clinical applications.